BusinessIGC Partners to Advance Cannabinoid Based Parkinson's Disease Therapy Research -- CFN MediaBy Nasdaq OMXMar 14, 2018, 1:00 PM UTC
BusinessAmarantus Subsidiary MANF Therapeutics Announces Positive Independent Peer-Reviewed Pre-Clinical Data for MANF in Parkinson’s DiseaseBy Nasdaq OMXJan 29, 2018, 2:02 PM UTC
BusinessUS FDA Grants Orphan Drug Designation for Retrotope’s RT001 in the Treatment of Phospholipase 2G6 (PLA2G6)-Associated NeurodegenerationBy Nasdaq OMXNov 2, 2017, 1:00 PM UTC
BusinessStudy of Retrotope’s deuterated polyunsaturated fatty acid drugs published in The FEBS JournalBy Nasdaq OMXOct 30, 2017, 1:01 PM UTC
